24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Direct Offering
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:09
Israel’s cyber industry bets identity will become the next AI security battleground
10:13
Israeli startups raised $1.5 billion in July as investors doubled down on enterprise AI
09:48
Why Israel may need to take its most secret missile maker public
21:59
Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount
More stories
Buzz
Most popular
Daily
Weekly
1
Israel searches for technology that could find soldiers and pilots who cannot call for help
2
Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount
3
After IAI and Rafael, secretive missile engine maker Tomer moves toward an IPO
4
ServiceNow continues layoffs as it restructures around AI
5
Israel's Iron Dome and Arrow makers unlikely to reach the IPO market before 2027 as Tomer joins the queue
More news
Direct Offering
4 stories about Direct Offering
Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering
10.07.18
|
CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering
17.06.18
|
Dror Reich
The Israel-based cancer immunotherapy company intends to use the proceedings for product development
OrbiMed Invests $16 Million in Derma Company Foamix
17.04.18
|
Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
Liver Treatment Company Galmed is Raising $6 Million in Direct Offering
04.04.18
|
Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014